Japan, March 25 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'FORMULATION AND DRUG PRODUCT WITH REDUCED PARTICLE FORMATION.' Other related details are as follows:

Application Number: JP,2024-200392

Category (FI): A61K47/42,C07K16/18,C12N9/16,A61K39/395@M,A61K47/26,A61K9/08

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Nov. 18, 2024

Publication Date: Jan. 30, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....